JAKAVI ruxolitinib (as phosphate) 20 mg tablet blister pack

Approval Id: e2a623eef0e0ff63
Product Name: JAKAVI ruxolitinib (as phosphate) 20 mg tablet blister pack
Artg Id: 198933
Artg Name: JAKAVI ruxolitinib (as phosphate) 20 mg tablet blister pack
Sponsor: Novartis Pharmaceuticals Australia Pty Ltd
Company Detail Path: /organization/novartis-pharmaceuticals-australia-pty-ltd
Artg Date: 2013-07-03
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/f5dcbb2159d5f70fa1e7cbcb0436c3a2.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/812be29f78a04f39a4027b1df297a4e0.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

e2a623eef0e0ff63

Type

Standard